Home NDC 55150-192 Adenosine
Product NDC 55150-192
11-digit product format 551500192
Labeler code 55150
Product ID 55150-192_3329ba34-b3ed-4517-8055-38c522dcf0b0
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Adenosine
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Eugia US LLC
Application ANDA205331
Marketing category ANDA
Marketing start 2017-11-02
Substance ADENOSINE
Active strength 60 mg/20mL
Pharmacologic classes Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A205331-001 ADENOSINE ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 A205331-002 ADENOSINE ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A205331-001 ADENOSINE 60MG/20ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A205331-002 ADENOSINE 90MG/30ML (3MG/ML) SOLUTION / INTRAVENOUS AP 2017-11-02 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Adenosine
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ADENOSINE 60 mg/20mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination K72T3FS567 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1654035 Internal RxNorm lookup 1654040 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55150-192-01 Adenosine 1 in 1 CARTON INJECTION, SOLUTION 1 5 55150-192-01 Adenosine 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 20 5 55150-192-20 Adenosine 10 in 1 CARTON INJECTION, SOLUTION 10 5 55150-192-20 Adenosine 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 20 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55150-192 ADENOSINE INJECTION, SOLUTION [EUGIA US LLC] 5 Current NDC, Legacy NDC, 4 package rows 20231222_61d9b8f6-f93f-46ee-bec2-db8d46999792.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 55150-192-01 55150019201 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-192-01) / 20 mL in 1 VIAL, SINGLE-DOSE 2017-11-02 0000-00-00 No No Current 55150-192-20 55150019220 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-192-20) / 20 mL in 1 VIAL, SINGLE-DOSE 2017-11-02 0000-00-00 No No Current